CTCAE Task Force

The SITC CTCAE Task Force is focused on the development of a module that details considerations of unique immune-related adverse events that arise during treatment with immunotherapy for incorporation into future versions of the Common Terminology Criteria for Adverse Effects (CTCAE). The Taskforce represents the society when requested and develops talking points for the Board of Directors when asked.


James L. Gulley, MD, PhD, FACP
National Cancer Institute

Current Members
0 Members